Wednesday, November 17, 2021
Print Current Session:
|
|
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS)
|
|
SESSION 26 SCHEDULE | |
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs | |
10:18 AM - 10:23 AM | Cost Effectiveness Of Drug Eluting Technologies For Femoropopliteal Lesions: They Are Worth The Increased Device Costs |
Presenter(s):Stefan Müller-Hülsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
10:24 AM - 10:29 AM | Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With Fempop Lesions At 4 Years In The ILLUMENATE RCT |
Presenter(s):Sean P. Lyden, MD Location: Grand Ballroom East, 3rd Floor |
|
10:30 AM - 10:35 AM | Pooled Data From The In.Pact RCT DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Continued Use Is Justified |
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD Location: Grand Ballroom East, 3rd Floor |
|
10:36 AM - 10:41 AM | New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 4-Year Results With TASC A/B Lesions Versus TASC C/D Lesions |
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
10:42 AM - 10:47 AM | Value Of In.Pact DCBs For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry |
Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
10:48 AM - 10:53 AM | Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages |
Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD Location: Grand Ballroom East, 3rd Floor |
|
10:54 AM - 10:59 AM | Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA |
Presenter(s):Marianne Brodmann, MD Location: Grand Ballroom East, 3rd Floor |
|
11:00 AM - 11:05 AM | New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment |
Presenter(s):Michael D. Dake, MD Location: Grand Ballroom East, 3rd Floor |
|
11:06 AM - 11:11 AM | 3-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Zilver PTX DES (Cook) With The Eluvia DES (Boston Scientific): Both Are Safe And Effective: Is There A Difference |
Presenter(s):William A. Gray, MD / Stefan Müller-Hülsbeck, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
11:12 AM - 11:18 AM | Panel Discussion |
NEW INFORMATION ON BTK DCBs AND DESs | |
11:18 AM - 11:23 AM | Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And Challenges With Treating CLTI Patients |
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
11:24 AM - 11:29 AM | 1-Year Results Of The Lutonix 0.14 DCB (Becton Dickinson) RCT Versus POBA Mostly For CLTI: DCB Has Equal Safety But 6-Month Patency Advantage Not Present At 1 Year |
Presenter(s):Patrick J. Geraghty, MD / Jihad A. Mustapha, MD / Marianne Brodmann, MD / William A. Gray, MD / Dierk Scheinert, MD Location: Grand Ballroom East, 3rd Floor |
|
11:30 AM - 11:35 AM | 2-Year Results Of Global Registry Of Lutonix BTK DCBs Mostly For CLTI Show Safety And Reasonable Effectiveness |
Presenter(s):Dierk Scheinert, MD / Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
11:36 AM - 11:41 AM | 1-Year Results From The AcoArt II BTK DCB RCT Show Safety (No Increased Mortality) And Improved Patency Versus POBA |
Presenter(s):Wei Guo, MD / Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
11:42 AM - 11:47 AM | Why BTK DCB Trials Do Not Show Uniformly Better Results: Technical Factors Matter |
Presenter(s):Francesco Liistro, MD Location: Grand Ballroom East, 3rd Floor |
|
11:48 AM - 11:53 AM | Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions |
Presenter(s):Jihad A. Mustapha, MD / Miguel F. Montero-Baker, MD Location: Grand Ballroom East, 3rd Floor |
|
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 26 | |
previous | next |